← brief for 2026-09-08 · Slowing decline

Serum phoenixin-14 levels in chronic kidney disease and hemodialysis patients: a cross-sectional study

Paper C Peer reviewed Observational

Key takeaways

Phoenixin-14 is a small body-made signalling molecule tied to appetite and metabolism. Researchers measured its blood level once in people with kidney disease and people on dialysis, and compared it with their other test results. Levels differed between the groups. Because everyone was measured at a single point in time, this shows a link only, not cause. There is no treatment here.

Who did this work

Erdoğan Özdemir (Botkin Hospital) · Fatih Genç (Botkin Hospital) · Türkan Yilmaz (Botkin Hospital) · Deccane Duzencı (Sekisui Chemical (Japan))

Source

Paper · OpenAlex, CKD works · 2026-09-07
https://doi.org/10.3389/fmed.2026.1896542